Yale Pressed to Help Cut Drug Costs in Africa

Yale University has become entangled in the battle to get inexpensive AIDS drugs to Africa. The medical charity Doctors Without Borders has asked the school to allow South Africa to import a generic version of d4T, a Bristol-Myers Squibb (BMS) drug on which Yale holds the patent. While the university -- noting a patent deal with BMS -- rejected the charity's request, Yale issued a statement Friday noting it had eliminated any barriers to the drug company supplying the drug in South Africa. In an effort to help the drug -- which is sold by BMS under the brand name Zerit -- reach South Africa, a group of law students at Yale has been planning to pressure the school and has alleged that there are possible conflicts of interest between BMS and the university.

Other CDC News for March 12, 2001

South Africa May Cite Crisis to Lower Cost of AIDS Drugs Yale Pressed to Help Cut Drug Costs in Africa Merck & Co. Advertisement Behind Cipla's Offer of Cheap AIDS Drugs: Potent Mix of Motives	Africa: Ivory Coast Makes Deal for Cheaper HIV Drugs AIDS Permeates Uganda Politics Too Public Health Spending Up in City, Town of Burlington; Sexually Transmitted Disease Cases Jumped 50 Percent From 1999 Russians Admit to 300,000 HIV Cases
Insulin Resistance in HIV Lipodystrophy Syndrome